A clinical trial of puberty-blocking drugs for adolescents can proceed after a High Court judge dismissed a legal challenge on Friday, July 31, 2026. The ruling allows researchers at King's College London to begin recruiting approximately 226 children, aged 11 to 16, for the NHS-funded PATHWAYS study starting August 1.